NASDAQ:MLABMesa Laboratories Stock Price, Forecast & News

$258.16

+9.26 (+3.72 %)

(As of 05/26/2020 04:00 PM ET)

Add

Compare

Today's Range

$253.71

Now: $258.16▼

$259.95

50-Day Range

$209.03

MA: $230.72▼

$248.90

52-Week Range

$181.21

Now: $258.16▼

$271.46

Volume23,331 shs

Average Volume39,399 shs

Market Capitalization$1.13 billion

P/E Ratio230.50

Dividend Yield0.26%

Beta0.36

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products. The company's Instruments segment offers data loggers, which are precision instruments used in critical manufacturing, quality control, and validation applications; medical meters and calibration solutions used to test various parameters of the dialysis fluid, and the calibration and operation of the dialysis machine; gas flow calibration and air sampling equipment that are used for industrial hygiene assessments, calibration of gas metering equipment, and environmental air monitoring; and torque testing systems used for measure bottle cap tightness. This segment's products are used in healthcare, pharmaceutical, medical device, food and beverage, industrial hygiene, and environmental air sampling industries. Its Sterilization and Disinfection Control segment manufactures and markets biological indicators comprising spore strips, self-contained products, and culture media, as well as process challenge devices; and testing services. This segment also distributes chemical indicators that are used to assess the effectiveness of sterilization processes; and cleaning indicators, which are used to assess the effectiveness of cleaning processes. The company's Cold Chain Monitoring segment offers systems, which are used to monitor various environmental parameters, such as temperature, humidity, and differential pressure for use in hospitals, pharmaceutical and medical device manufacturers, blood banks, pharmacies, and laboratory environments; parameter monitoring services for products in a cold chain; and consulting services. Its Cold Chain Packaging segment offers packaging development consulting services and thermal packaging products. The company markets its products through distributors in Europe, Africa, Asia, South America, Australia, Canada, and Central America. Mesa Laboratories, Inc. was founded in 1982 and is headquartered in Lakewood, Colorado.

Beat the Market (BTM) Rank^™

1.5 Analyst's Opinion

Consensus Rating
Mesa Laboratories has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $262.50, Mesa Laboratories has a potential upside of 1.7% from its current price of $258.16.
Amount of Analyst Coverage
Mesa Laboratories has received no research coverage in the past 90 days.

2.6 Community Rank

Outperform Votes
Mesa Laboratories has received 205 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Mesa Laboratories has received 188 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Mesa Laboratories has received 52.16% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Mesa Laboratories and other stocks. Vote “Outperform” if you believe MLAB will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MLAB will underperform the S&P 500 over the long term. You may vote once every thirty days.

3.3 Dividend Strength

Dividend Leadership
Mesa Laboratories is a leading dividend payer. It pays a dividend yield of 0.26%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Mesa Laboratories does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Mesa Laboratories is 11.92 %. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Mesa Laboratories will have a dividend payout ratio of 8.44 % next year. This indicates that Mesa Laboratories will be able to sustain or increase its dividend.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Mesa Laboratories insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $435,746.00 in company stock.
Percentage Held by Insiders
Only 10.03% of the stock of Mesa Laboratories is held by insiders.
Percentage Held by Institutions
94.83% of the stock of Mesa Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3 Earnings and Valuation

Earnings Growth
Earnings for Mesa Laboratories are expected to grow by 24.47% in the coming year, from $6.09 to $7.58 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Mesa Laboratories is 230.50, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 14.07.
Price to Earnings Ratio vs. Sector
The P/E ratio of Mesa Laboratories is 230.50, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.20.
Price to Book Value per Share Ratio
Mesa Laboratories has a P/B Ratio of 8.97. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.94 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Process control instruments

Sub-IndustryElectronic Equipment & Instruments

SectorMedical

Current SymbolNASDAQ:MLAB

Previous Symbol

CUSIP59064R10

CIK724004

Webwww.mesalabs.com

Phone303-987-8000

Debt

Debt-to-Equity Ratio0.59

Current Ratio4.78

Quick Ratio4.04

Price-To-Earnings

Trailing P/E Ratio230.50

Forward P/E Ratio42.39

P/E GrowthN/A

Sales & Book Value

Annual Sales$103.14 million

Price / Sales10.94

Cash Flow$8.33 per share

Price / Cash Flow30.99

Book Value$28.77 per share

Price / Book8.97

Profitability

EPS (Most Recent Fiscal Year)$5.37

Net Income$7.48 million

Net Margins4.03%

Return on Equity10.14%

Return on Assets6.21%

Miscellaneous

Employees366

Outstanding Shares4,371,000

Market Cap$1.13 billion

Next Earnings Date6/1/2020 (Estimated)

OptionableNot Optionable

Receive MLAB News and Ratings via Email

Sign-up to receive the latest news and ratings for MLAB and its competitors with MarketBeat's FREE daily newsletter.

Mesa Laboratories (NASDAQ:MLAB) Frequently Asked Questions

How has Mesa Laboratories' stock been impacted by COVID-19 (Coronavirus)?

Mesa Laboratories' stock was trading at $230.99 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MLAB shares have increased by 11.8% and is now trading at $258.16. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Mesa Laboratories?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mesa Laboratories in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Mesa Laboratories.

When is Mesa Laboratories' next earnings date?

Mesa Laboratories is scheduled to release its next quarterly earnings announcement on Monday, June 1st 2020. View our earnings forecast for Mesa Laboratories.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) announced its earnings results on Monday, February, 10th. The medical instruments supplier reported ($1.06) EPS for the quarter, missing analysts' consensus estimates of $0.88 by $1.94. The medical instruments supplier had revenue of $31.66 million for the quarter, compared to the consensus estimate of $31.05 million. Mesa Laboratories had a net margin of 4.03% and a return on equity of 10.14%. View Mesa Laboratories' earnings history.

How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?

Mesa Laboratories declared a quarterly dividend on Wednesday, April 1st. Investors of record on Friday, May 29th will be given a dividend of $0.16 per share on Monday, June 15th. This represents a $0.64 annualized dividend and a dividend yield of 0.25%. The ex-dividend date is Thursday, May 28th. View Mesa Laboratories' dividend history.

What price target have analysts set for MLAB?

2 analysts have issued 1 year price objectives for Mesa Laboratories' shares. Their forecasts range from $250.00 to $275.00. On average, they expect Mesa Laboratories' stock price to reach $262.50 in the next year. This suggests a possible upside of 1.7% from the stock's current price. View analysts' price targets for Mesa Laboratories.

Has Mesa Laboratories been receiving favorable news coverage?

News stories about MLAB stock have trended somewhat negative this week, InfoTrie reports. The research group ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Mesa Laboratories earned a media sentiment score of -1.9 on InfoTrie's scale. They also assigned headlines about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutMesa Laboratories.

Who are some of Mesa Laboratories' key competitors?

Some companies that are related to Mesa Laboratories include Cognex (CGNX), FLIR Systems (FLIR), National Instruments (NATI), Coherent (COHR), Itron (ITRI), Badger Meter (BMI), OSI Systems (OSIS), FARO Technologies (FARO), MTS Systems (MTSC), Vishay Precision Group (VPG) and Daktronics (DAKT). View all competitors.

What other stocks do shareholders of Mesa Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mesa Laboratories investors own include NVIDIA (NVDA), Verizon Communications (VZ), Alibaba Group (BABA), Gilead Sciences (GILD), Intel (INTC), Coupa Software (COUP), Altria Group (MO), Micron Technology (MU), Exxon Mobil (XOM) and Appian (APPN).

Who are Mesa Laboratories' key executives?

Mesa Laboratories' management team includes the following people:

Mr. Gary M. Owens, CEO, Pres & Director (Age 51)
Mr. John V. Sakys, Chief Financial Officer, Chief Accounting Officer, Sec. & Treasurer (Age 50)
Mr. Gregory T. DiNoia, Sr. VP of Commercial Operations (Age 54)
Ms. Helene R. Leone, Gen. Counsel
Mr. Peter Jung, VP of Corp. Devel. & Strategy

What is Mesa Laboratories' stock symbol?

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

Who are Mesa Laboratories' major shareholders?

Mesa Laboratories' stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (15.78%), Conestoga Capital Advisors LLC (10.30%), Invesco Ltd. (5.38%), Ranger Investment Management L.P. (3.99%), State Street Corp (3.50%) and Atlanta Capital Management Co. L L C (2.79%). Company insiders that own Mesa Laboratories stock include Brian David Archbold, David M Kelly, Evan Guillemin, H Stuart Campbell, John Bradley Schmieder, John James Sullivan, John Sakys, Michael T Brooks, Robert V Dwyer and Seg Ventures, Llc. View institutional ownership trends for Mesa Laboratories.

Which institutional investors are selling Mesa Laboratories stock?

MLAB stock was sold by a variety of institutional investors in the last quarter, including Geode Capital Management LLC, THB Asset Management, BlackRock Inc., Morgan Stanley, Morgan Stanley, Teton Advisors Inc., Citigroup Inc., and UBS Group AG. Company insiders that have sold Mesa Laboratories company stock in the last year include Brian David Archbold, Evan Guillemin, John Bradley Schmieder, John James Sullivan, and Robert V Dwyer. View insider buying and selling activity for Mesa Laboratories.

Which institutional investors are buying Mesa Laboratories stock?

MLAB stock was purchased by a variety of institutional investors in the last quarter, including Invesco Ltd., Eagle Asset Management Inc., Wells Fargo & Company MN, Aviva PLC, Russell Investments Group Ltd., Moody Aldrich Partners LLC, Atlanta Capital Management Co. L L C, and State Street Corp. View insider buying and selling activity for Mesa Laboratories.

How do I buy shares of Mesa Laboratories?

Shares of MLAB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Mesa Laboratories' stock price today?

One share of MLAB stock can currently be purchased for approximately $258.16.

How big of a company is Mesa Laboratories?

Mesa Laboratories has a market capitalization of $1.13 billion and generates $103.14 million in revenue each year. The medical instruments supplier earns $7.48 million in net income (profit) each year or $5.37 on an earnings per share basis. Mesa Laboratories employs 366 workers across the globe.

What is Mesa Laboratories' official website?

The official website for Mesa Laboratories is www.mesalabs.com.

How can I contact Mesa Laboratories?

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The medical instruments supplier can be reached via phone at 303-987-8000 or via email at [email protected]

This page was last updated on 5/26/2020 by MarketBeat.com Staff